Metformin Ratiopharm

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Ratiopharm (Metformin Hydrochloride)

Q: What is Metformin Ratiopharm used for?

Metformin Ratiopharm is used to improve blood glucose control in adults with type 2 diabetes mellitus and other insulin‑resistance conditions such as prediabetes and polycystic ovary syndrome. It works by lowering hepatic glucose production and enhancing peripheral insulin sensitivity.

Q: How does Metformin work in the body?

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver gluconeogenesis, reduces intestinal glucose absorption, and increases muscle glucose uptake. These combined actions lower circulating glucose levels without stimulating insulin secretion.

Q: What is the usual dose of Metformin Ratiopharm?

The dosage of Metformin Ratiopharm is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerance. The prescriber determines the appropriate strength, frequency, and titration schedule.

Q: Is Metformin safe during pregnancy or breastfeeding?

Safety data for Metformin in pregnancy are limited, and the product’s pregnancy category is unknown. It should only be used if the potential benefit justifies the potential risk. Metformin is excreted in breast milk; breastfeeding mothers should consult their healthcare provider before use.

Q: How do I order Metformin Ratiopharm from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin compare with other antidiabetic drugs?

Metformin is a first‑line biguanide that improves insulin sensitivity without causing weight gain, unlike sulfonylureas which stimulate insulin release and may cause hypoglycaemia. Compared with newer agents such as SGLT2 inhibitors, Metformin has a long safety record, lower cost, and no associated risk of genital infections.

Q: What are the storage requirements for Metformin Ratiopharm?

Metformin Ratiopharm tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Q: How is Metformin Ratiopharm administered?

Metformin Ratiopharm is taken orally, usually with meals to minimise gastrointestinal upset. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or during acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Ratiopharm?

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or other biguanides.

Metformin, the active ingredient in Metformin Ratiopharm, is a biguanide presented as a tablet for oral use. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistance conditions.

GNH India supplies Metformin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Ratiopharm is a biguanide indicated for disorders of glucose metabolism and related insulin‑resistance states.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels.
Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes.
Polycystic ovary syndrome (PCOS): improves insulin sensitivity and may help regulate menstrual cycles.

How It Works

Metformin reduces hepatic gluconeogenesis, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). These actions collectively lower circulating glucose without stimulating insulin secretion, helping to achieve better glycaemic control in insulin‑resistant patients.

Side Effects

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects

Nausea: mild to moderate stomach upset.
Diarrhea: frequent loose stools, especially at treatment initiation.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient alteration of taste perception.
Weight loss: modest reduction in body weight.
Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening metabolic acidosis.
Severe hypoglycaemia: when combined with insulin or secretagogues.
Hepatic failure: worsening liver function may precipitate toxicity.
Stevens‑Johnson syndrome: severe skin reactions.
Anemia: hemolytic or aplastic processes.
Pancreatitis: inflammation of the pancreas.

Precautions & Warnings

Metformin requires careful monitoring and patient education to minimise risks.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic function monitoring: contraindicated in acute liver disease.
Lactic acidosis risk: discontinue before surgeries or radiographic contrast procedures.
Elderly patients: start at lower doses and titrate slowly.
Alcohol consumption: limit intake to reduce lactic acidosis risk.
Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: may raise plasma metformin concentrations.
Rifampicin: reduces metformin exposure, potentially diminishing glucose‑lowering effect.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemia symptoms.
Diuretics (loop or thiazide): can affect renal clearance of metformin.
ACE inhibitors/ARBs: monitor renal function when combined.
Alcohol: enhances risk of lactic acidosis, especially with excessive intake.

Frequently Asked Questions

Metformin Ratiopharm is used to improve blood glucose control in adults with type 2 diabetes mellitus and other insulin‑resistance conditions such as prediabetes and polycystic ovary syndrome. It works by lowering hepatic glucose production and enhancing peripheral insulin sensitivity.

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver gluconeogenesis, reduces intestinal glucose absorption, and increases muscle glucose uptake. These combined actions lower circulating glucose levels without stimulating insulin secretion.

The dosage of Metformin Ratiopharm is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerance. The prescriber determines the appropriate strength, frequency, and titration schedule.

Safety data for Metformin in pregnancy are limited, and the product’s pregnancy category is unknown. It should only be used if the potential benefit justifies the potential risk. Metformin is excreted in breast milk; breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line biguanide that improves insulin sensitivity without causing weight gain, unlike sulfonylureas which stimulate insulin release and may cause hypoglycaemia. Compared with newer agents such as SGLT2 inhibitors, Metformin has a long safety record, lower cost, and no associated risk of genital infections.

Metformin Ratiopharm tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Metformin Ratiopharm is taken orally, usually with meals to minimise gastrointestinal upset. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or during acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or other biguanides.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.